Aethlon Historical Financial Ratios
| AEMD Stock | USD 0.37 0 0.27% |
Aethlon Medical is presently reporting on over 106 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 0.79 or Days Sales Outstanding of 80.47 will help investors to properly organize and evaluate Aethlon Medical financial condition quickly.
Aethlon |
About Aethlon Financial Ratios Analysis
Aethlon MedicalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Aethlon Medical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Aethlon financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Aethlon Medical history.
Aethlon Medical Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Aethlon Medical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Aethlon Medical sales, a figure that is much harder to manipulate than other Aethlon Medical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Stock Based Compensation To Revenue
A metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards.Capex To Depreciation
The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.Most ratios from Aethlon Medical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Aethlon Medical current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.At present, Aethlon Medical's Book Value Per Share is projected to increase significantly based on the last few years of reporting. The current year's Average Payables is expected to grow to about 792.3 K, whereas Days Sales Outstanding is forecasted to decline to 80.47.
| 2021 | 2023 | 2024 (projected) | Graham Number | 42.94 | 15.84 | 15.05 | Receivables Turnover | 2.3 | 2.64 | 2.51 |
Aethlon Medical fundamentals Correlations
Click cells to compare fundamentals
Aethlon Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aethlon Medical fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 7.98 | 37.24 | 73.24 | 13.59 | 15.63 | 14.85 | |
| Ptb Ratio | 0.55 | 2.6 | 1.26 | 0.52 | 0.75 | 0.79 | |
| Book Value Per Share | 27.17 | 7.69 | 11.51 | 7.34 | 2.29 | 2.41 | |
| Free Cash Flow Yield | (1.03) | (0.28) | (0.47) | (1.47) | (2.39) | (2.27) | |
| Operating Cash Flow Per Share | (15.22) | (5.6) | (6.62) | (5.12) | (4.03) | (4.23) | |
| Average Payables | 304.4K | 128.2K | 208.5K | 466.4K | 605.4K | 792.3K | |
| Stock Based Compensation To Revenue | 1.3 | 1.18 | 2.55 | 1.83 | 1.65 | 1.94 | |
| Pb Ratio | 0.55 | 2.6 | 1.26 | 0.52 | 0.75 | 0.79 | |
| Ev To Sales | (6.57) | 22.34 | 17.68 | (9.61) | (11.05) | (10.5) | |
| Free Cash Flow Per Share | (15.66) | (5.64) | (6.86) | (5.57) | (4.13) | (4.34) | |
| Roic | (0.63) | (0.84) | (0.61) | (0.79) | (2.19) | (2.08) | |
| Net Income Per Share | (18.67) | (6.52) | (7.06) | (5.86) | (4.86) | (5.1) | |
| Sales General And Administrative To Revenue | 6.31 | 7.44 | 19.34 | 13.08 | 11.77 | 6.3 | |
| Research And Ddevelopement To Revenue | 1.43 | 3.14 | 7.96 | 4.78 | 4.3 | 2.26 | |
| Cash Per Share | 28.13 | 8.16 | 11.57 | 7.08 | 2.17 | 2.06 | |
| Pocfratio | (1.0) | (3.63) | (2.21) | (0.74) | (0.43) | (0.45) | |
| Interest Coverage | (13.36) | (27.21) | (109.34) | (5.0K) | (5.7K) | (5.5K) | |
| Pfcf Ratio | (0.97) | (3.6) | (2.13) | (0.68) | (0.42) | (0.44) | |
| Roe | (0.68) | (0.84) | (0.61) | (0.8) | (2.12) | (2.01) | |
| Pe Ratio | (0.81) | (3.11) | (2.07) | (0.65) | (0.36) | (0.37) | |
| Return On Tangible Assets | (0.62) | (0.74) | (0.54) | (0.69) | (1.48) | (1.55) | |
| Ev To Free Cash Flow | 0.8 | (2.16) | (0.51) | 0.48 | 0.0149 | 0.0156 | |
| Earnings Yield | (1.23) | (0.32) | (0.48) | (1.54) | (2.81) | (2.67) | |
| Intangibles To Total Assets | 0.005536 | 0.005338 | 1.13E-4 | 9.4E-5 | 1.33E-4 | 1.27E-4 | |
| Net Debt To E B I T D A | 1.5 | 1.25 | 1.59 | 1.14 | 0.38 | 0.4 | |
| Current Ratio | 9.4 | 7.53 | 9.95 | 10.03 | 3.25 | 2.15 | |
| Tangible Book Value Per Share | 27.0 | 7.64 | 11.51 | 7.33 | 2.29 | 2.41 | |
| Graham Number | 107.57 | 33.83 | 42.94 | 31.09 | 15.84 | 15.05 | |
| Shareholders Equity Per Share | 27.55 | 7.8 | 11.61 | 7.34 | 2.29 | 2.41 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.79) | Revenue Per Share 0.236 | Quarterly Revenue Growth 42.782 | Return On Assets (0.50) | Return On Equity (1.05) |
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.